These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27608932)

  • 41. Simultaneous development of acute disseminated encephalomyelitis and Guillain-Barré syndrome associated with H1N1 09 influenza vaccination.
    Hoshino T; Uchiyama Y; Ito E; Osawa S; Ohashi T
    Intern Med; 2012; 51(12):1595-8. PubMed ID: 22728497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiological characteristics of acute disseminated encephalomyelitis in Nanchang, China: a retrospective study.
    Xiong CH; Yan Y; Liao Z; Peng SH; Wen HR; Zhang YX; Chen SH; Li J; Chen HY; Feng XW; Yao HQ; Huang L; Zhang L
    BMC Public Health; 2014 Feb; 14():111. PubMed ID: 24495742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influenza vaccination and intention to receive the pandemic H1N1 influenza vaccine among healthcare workers of British Columbia, Canada: a cross-sectional study.
    Kaboli F; Astrakianakis G; Li G; Guzman J; Donovan T; Naus M
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1017-24. PubMed ID: 20707670
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute disseminated encephalomyelitis and transverse myelitis following COVID-19 vaccination - A self-controlled case series analysis.
    Morgan HJ; Clothier HJ; Sepulveda Kattan G; Boyd JH; Buttery JP
    Vaccine; 2024 Apr; 42(9):2212-2219. PubMed ID: 38350771
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estimating the Burden of Pandemic Infectious Disease: The Case of the Second Wave of Pandemic Influenza H1N1 in Forsyth County, North Carolina.
    Peters TR; Snively BM; Suerken CK; Bischoff W; Vannoy L; Blakeney E; Bischoff T; Palavecino E; Sherertz R; Poehling KA
    N C Med J; 2016; 77(1):15-22. PubMed ID: 26763239
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.
    Ropero-Álvarez AM; Whittembury A; Bravo-Alcántara P; Kurtis HJ; Danovaro-Holliday MC; Velandia-González M
    Vaccine; 2015 Jan; 33(1):187-92. PubMed ID: 25444798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaccines and the risk of acute disseminated encephalomyelitis.
    Chen Y; Ma F; Xu Y; Chu X; Zhang J
    Vaccine; 2018 Jun; 36(26):3733-3739. PubMed ID: 29784468
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.
    Nakayama T; Onoda K
    Vaccine; 2007 Jan; 25(3):570-6. PubMed ID: 16945455
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Possible Impact of Yearly Childhood Vaccination With Trivalent Inactivated Influenza Vaccine (TIV) on the Immune Response to the Pandemic Strain H1N1.
    Amer A; Fischer H; Li X; Asmar B
    Clin Pediatr (Phila); 2016 Mar; 55(3):245-50. PubMed ID: 26159622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pandemic A/H1N1 2009 influenza vaccination, preceding infections and clinical findings in UK children with Guillain-Barré syndrome.
    Verity C; Stellitano L; Winstone AM; Stowe J; Andrews N; Miller E
    Arch Dis Child; 2014 Jun; 99(6):532-8. PubMed ID: 24585755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Attitudes and side effects related to pandemic influenza A (H1N1) vaccination in healthcare personnel].
    Ormen B; Türker N; Vardar I; Kaptan F; El S; Ural S; Kaya F; Coşkun NA
    Mikrobiyol Bul; 2012 Jan; 46(1):57-64. PubMed ID: 22399172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pandemic influenza A (H1N1)v vaccination status and factors affecting vaccination: Ankara and Diyarbakır 2009 data from Turkey].
    Ertek M; Sevencan F; Kalaycıoğlu H; Gözalan A; Simşek C; Culha G; Dorman V; Ozlü A; Arıkan F; Aktaş D; Akın L; Korukluoğlu G; Sevindi DF
    Mikrobiyol Bul; 2011 Oct; 45(4):684-96. PubMed ID: 22090299
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Post-vaccination encephalomyelitis: literature review and illustrative case.
    Huynh W; Cordato DJ; Kehdi E; Masters LT; Dedousis C
    J Clin Neurosci; 2008 Dec; 15(12):1315-22. PubMed ID: 18976924
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Is the use of the trivalent influenza vaccine against A (H1N1) pdm09 associated with an increased risk of post-vaccination acute disseminated encephalomyelitis?].
    Arai M
    Rinsho Shinkeigaku; 2015; 55(4):270-1. PubMed ID: 25904260
    [No Abstract]   [Full Text] [Related]  

  • 55. Neurologic adverse events following influenza A (H1N1) vaccinations in children.
    Lee SJ; Kim YO; Woo YJ; Kim MK; Nam TS; Cho YK
    Pediatr Int; 2012 Jun; 54(3):325-30. PubMed ID: 22299607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute encephalomyelitis syndromes associated with H1N1 09 influenza vaccination.
    Denholm JT; Neal A; Yan B; Petty S; Knox J; French C; Marshall C
    Neurology; 2010 Dec; 75(24):2246-8. PubMed ID: 21172848
    [No Abstract]   [Full Text] [Related]  

  • 57. Incidence of Pediatric Acute Disseminated Encephalomyelitis During the Coronavirus Disease 2019 Pandemic in South Korea.
    Hwang J; Chae SA; Lim BC; Choi SA
    Pediatr Neurol; 2023 Sep; 146():44-49. PubMed ID: 37429226
    [TBL] [Abstract][Full Text] [Related]  

  • 58. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.
    Dodd CN; Romio SA; Black S; Vellozzi C; Andrews N; Sturkenboom M; Zuber P; Hua W; Bonhoeffer J; Buttery J; Crawford N; Deceuninck G; de Vries C; De Wals P; Gutierrez-Gimeno MV; Heijbel H; Hughes H; Hur K; Hviid A; Kelman J; Kilpi T; Chuang SK; Macartney K; Rett M; Lopez-Callada VR; Salmon D; Gimenez-Sanchez F; Sanz N; Silverman B; Storsaeter J; Thirugnanam U; van der Maas N; Yih K; Zhang T; Izurieta H;
    Vaccine; 2013 Sep; 31(40):4448-58. PubMed ID: 23770307
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and immunogenicity of an MF59-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age.
    Knuf M; Leroux-Roels G; Rümke HC; Abarca K; Rivera L; Lattanzi M; Pedotti P; Arora A; Kieninger-Baum D; Della Cioppa G
    Vaccine; 2015 Jan; 33(1):174-81. PubMed ID: 25444803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bithalamic compromise in acute disseminated encephalomyelitis following H1N1 influenza vaccine.
    Fernandes AF; Marchiori PE
    Arq Neuropsiquiatr; 2011 Jun; 69(3):571. PubMed ID: 21755147
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.